Drug Search Results
More Filters [+]

Sulbutiamine

Alternative Names: sulbutiamine
Latest Update: 2024-07-12
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: N/A

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Brazil | Chile | Colombia | Dominican Republic | Ecuador | Egypt | France | Greece | Hong Kong | India | Indonesia | Lebanon | Malaysia | Malta | Mexico | Morocco | Pakistan | Peru | Philippines | Portugal | Romania | Russia | Singapore | Spain | Turkey | Ukraine | United Arab Emirates | Uruguay | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Sohag University
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Sulbutiamine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events